Renal denervation (RDN)

Find all the latest content on renal denervation (RDN) published on this website.

Despite the existence of effective antihypertensive drugs, arterial hypertension remains a critical challenge for healthcare systems worldwide. Can catheter-based renal denervation (RDN) play an effective part in reducing, previously untreatable high blood pressure? Follow the latest research in this novel field along with the critical issues of blood pressure monitoring, imaging modalities, tools, devices and techniques as well as vascular access, bleeding risk and adjunctive pharmacotherapy…

Filtered By
Renal denervation

93 results

Case report: Renal denervation using radiofrequency energy (rRDN)

20 Sep 2024

In this case report, we examine an advanced technique for renal denervation (RDN)—radiofrequency energy—employed to manage severe hypertension in patients with complex medical histories.

Joachim Weil

Author

Joachim Weil
Case report: Renal denervation using radiofrequency energy (rRDN)

The turning point in hypertension care: renal denervation in practice

04 Oct 2024 – From AICT-AsiaPCR 2024

Explore the latest advancements in hypertension care with this session on renal denervation. Stay up-to-date with the latest guidelines for hypertension treatment using renal denervation. Delve into the importance of patient selection and their preferences, and understand the key steps to perform a safe and effective...

The turning point in hypertension care: renal denervation in practice

Hypertension - the silver bullet of medicine

24 Sep 2024

In this Special Report, we describe how to safely integrate the latest additional guideline-recommended treatment option for some hypertensive patients - renal denervation.

Hypertension - the silver bullet of medicine

Editorial: Hypertension and Renal Denervation

20 Sep 2024

Hypertension is the number one cause of years of life lost, and, perhaps more importantly, years of healthy living lost. It causes at least half of all heart attacks and strokes and is the major driver of heart failure.

Andrew Sharp

Author

Andrew Sharp
Editorial: Hypertension and Renal Denervation

How to establish a renal denervation service

16 Oct 2024

 Andrew Sharp and Valérie Duchatelle discuss the key elements of establishing a service for a Renal Denervation (RDN) programme. They cover team-building strategies, patient selection criteria, and the comprehensive patient pathway—detailing everything from lab work and in-depth investigations to lifestyle education and long-term follow-up.

The Essentials -...

How to establish a renal denervation service

How to perform safe and effective renal denervation

20 Sep 2024

Following the recent inclusion of renal denervation as an approved therapy in the 2023 European Society of Hypertension guidelines, Andrew Sharp and Felix Mahfoud discuss patient selection (for those with resistant hypertension or uncontrolled blood pressure), setting up best practices, the safe and appropriate use of contrast, choosing...

How to perform safe and effective renal denervation

A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension

13 Nov 2024

Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension

Why hypertension is a major unresolved problem

02 Oct 2024

Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.

Sofie Brouwers

Author

Sofie Brouwers
Why hypertension is a major unresolved problem

The future of renal denervation in Europe: A five-year perspective

04 Nov 2024

This article assesses the future of RDN in Europe, considering recent technological, clinical, and regulatory developments.

Atul Pathak

Author

Atul Pathak
Dr Julien Adjedj

Author

Julien Adjedj
The future of renal denervation in Europe: A five-year perspective

uRDN now - The third pillar for hypertension treatment

16 May 2024 – From EuroPCR 2024

Tune into this session to stay updated on the cutting-edge clinical evidence, guidelines, and technology surrounding renal denervation. Explore firsthand clinical experiences with ultrasound renal denervation and gain practical insights into patient selection through individual, real-world case discussions. Engage in discussions on integrating ultrasound renal denervation...

uRDN now - The third pillar for hypertension treatment